Figure 7 | Scientific Reports

Figure 7

From: Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer

Figure 7

Identification of subclasses based on the screened SLC genes for CRC patients. (A,B) Two distinct subclasses (C1, C2) was identified by NMF clustering in the training set (A) and the testing set (B). The consensus map (a), PCA (b) and survival analysis (c) of two subclasses were shown. (C) The risk scores of two subclasses in the training set and testing set. (D) Sankey diagram for the two risk groups and two subtypes. ****P < 0.0001.

Back to article page